67SUMMARY
9 SUMMARY
Traumeel® is a multitarget, multicomponent medication that supports inflammation resolution, accelerates the healing process and provides sustained recovery from injury. [St Laurent 2017 & 2018, Jordan 2021, González de Vega 2013, Birnesser 2004, Schneider 2005, Muders 2016, 2017, Cesnulevicius 2011]
Traumeel® contains 14 natural ingredients working together to deliver effective and well tolerated relief of inflammation symptoms.[Cesnulevicius 2011, Lussignoli 1999]
Traumeel® is indicated as a first-line treatment for patients with traumatic injuries of all kinds such as sprains, dislocations, contusions, hemarthrosis and effusions into a joint. According to the research, Traumeel® regulates the inflammatory process in different organs and tissues, including acute, chronic, and degenerative disorders of the musculoskeletal system.
Traumeel® has a different mode of action to conventional anti-inflammatory drugs.[St Laurent 2017 & 2018, Jordan 2021]
Traumeel® has a well-established efficacy and safety profile: Randomized controlled studies have shown that Traumeel® is significantly
more effective than placebo and at least as effective as diclofenac in the treatment of musculoskeletal injury.[González 2013, Böhmer 1992, Zell 1989]
Observational cohort studies have shown Traumeel® to be at least comparable with conventional therapies in terms of resolution of symptoms and time to symptomatic improvement.[Zenner 1992, 1994, 1997, Schneider 2008]
Traumeel® ointment and gel is an effective alternative to topical diclofenac 1% gel in the treatment of ankle sprain. This has further added to the evidence- base for the use of Traumeel® in musculoskeletal injuries. A treatment algorithm has been developed to assist clinicians in the appropriate utilization of Traumeel® in clinical practice. Sporting institutions in Italy, Spain and Germany acknowledge Traumeel s efficacy and safety in their respective consensus guidelines or recommendations.
The MOZArT (Management of Osteoarthritis of the Knee with Zeel And Traumeel Injections) study, a large randomized controlled trial, demonstrated that Traumeel® and Zeel® T co-administered intra-articular injections are significantly superior to placebo in reducing knee pain in subjects with moderate-to-severe pain associated with knee osteoarthritis.[Lozada 2017]
The pain reduction of Traumeel® and Zeel® T in the MOZArT study is comparable to other intra-articular injection therapies and higher than for oral therapies.[Lozada 2017]
Tolerability of Traumeel® has been demonstrated to be significantly greater than with conventional treatments.
Safety studies have indicated that Traumeel® is unlikely to interfere with antimicrobial first defences, the normal homeostatic process, kidney function or liver function.